Over the last three decades protocols have been developed to generate and purify high titer stocks of recombinant adeno-associated viral vectors (rAAV). In early methods to produce rAAV an adenovirus was required as helper virus. As a result, batches of rAAV were contaminated with adenovirus. The identification of the adenoviral genes required for the propagation of rAAV vectors has allowed the creation of a rAAV production system that is entirely plasmid based [2] [3] [4] [5] . Today the nine most commonly used rAAV serotypes are produced by dual or triple plasmid transfections in human embryonic kidney (HEK) 293T cells. In the dual plasmid production system the transfer plasmid contains the gene of interest under the control of a promoter flanked by the ITRs from AAV2 and the helper plasmid harbors the AAV2 rep genes, the cap genes of a specific AAV serotype and the adenoviral helper functions 3 . In the triple plasmid production system the rep and cap genes and the adenoviral helper functions resent on two different plasmids 6 . Thus, for each rAAV serotype the helper plasmid harbors the specific cap genes of the desired serotype. Serotypes 1 to 6 are produced through the dual plasmid system and serotypes 7 to 9 by means of the triple plasmid system. Large scale production protocols for rAAV in either insect cells 7, 8 or mammalian cells 9 have also been developed. These production systems are mainly used to generate large amounts of rAAV for preclinical or clinical studies.
In this article a simple four stage production protocol is provided for the generation of relatively small quantities (100-200 μl) of rAAV with a titer typically ranging between 1 x 10 12 to 2 x 10 13 genomic copies/mL. The first stage involves the production of rAAV by cotransfection of two or three plasmids (the transfer plasmids mixed with one or two helper plasmids depending on the rAAV serotype) in HEK293T cells. In the second stage rAAV is collected from the transfected cells and concentrated by iodixanol gradient ultracentrifugation. Thirdly, rAAV from the iodixanol gradient is concentrated and separated from cellular proteins by multiple washes and centrifugation in Amicon centrifugal filter devices. Fourth, the titer of the rAAV sample is determined by quantitative PCR (qPCR) on rAAV genomic DNA. This protocol is a modification and extension of original protocols developed earlier and can be completed in 7 to 8 working days 4, 5, 10, 11 . Finally, we describe our method to deliver rAAV to the brain [12] [13] [14] [15] and to the retina by intravitreal injection 16, 17 . 4. Replace DMEM with IMDM two hours before the transfection.
Materials
5. Thaw the PEI solution (A) and prepare the plasmid solution (B) for transfection according to Table 2 . For AAV 1 to 6 a two plasmid system is used. For AAV 7 to 9 a three plasmid system is used (Table 1) [ Table 2 near here] Day 3.
9. Prewarm IMDM in a water bath to 37 o C. harvested on day 5. However, for AAV7 we consistently observed that the transfected cells start to detach from the cell culture dish on day 5 and with this serotype we therefore start the rAAV harvest on day 4.
Harvest of rAAV and iodixanol gradient ultracentrifugation
Day 5.
1. Aspirate medium from the cell culture plates. Two plates at a time. 
Iodixanol gradient centrifugation
Day 6 .
1. Defrost the cell lysate in a 37 o C water bath.
2. Centrifuge lysate for 30 min at 3220 x g in a table centrifuge. 7. Seal the tube using the electrical tube topper. Ensure that the neck of the Beckman tube is dry because the tube will not seal properly if the neck is wet.
Carefully squeeze the sealed Beckman tube to make sure that the tube is indeed fully sealed and not leaking. 12. Collect the first 2 mL of iodixanol (60% iodixanol) in a 15 mL tube and discard.
13. Collect the next 3 mL of iodixanol (1 mL of 60% and 2 mL of 40% iodixanol). This fraction contains your rAAV.
[ Figure 1 near here] 5. Add 15 mL of D-PBS plus 5% sucrose to the concentrated rAAV solution.
6. Centrifuge at 3220 x g for 10 minutes at RT to approximately 500 µL.
Repeat this at least three times (see Note 9).
8. In the last Amicon wash and concentration step centrifuge until the volume of your rAAV solution is between 150 and 200 µL. Additional centrifuging may be necessary to reduce the volume to this.
9. Transfer your rAAV to a screw-top 1.5 mL tube and store at -80 o C (see Note 10).
rAAV titration
Day 7. 
Stereotactic delivery of rAAV to the brain (in some jurisdictions this procedure
needs to be performed in a suitable biosafety cabinet)
1. Tubing is connected to the glass needle by application of the two component resin. The opposite side is mounted onto the Hamilton syringe needle, after which the system is back-filled using demi water.
2. The rat is deeply anesthetized with inhalation anesthesia using a mixture of O2 (0.2 L/min) and medicinal air (0.4 L/min) containing 1.6% isoflurane.
3. The fur on the skull is shaved and the skin surface is cleaned with 70% ethanol.
4. The animal is placed in a stereotactic frame and fixed by ear and tooth bars.
5.
A skin incision is made and lidocaine is topically applied to obtain additional local anesthesia.
Stereotactic coordinates for intraparenchymal injection are obtained from
Paxinos and Watson (see Note 12).
7.
A dental drill is used to drill a small hole in the skull at the intended coordinates. 11. Subsequently the needle is gently retracted and the skin is sutured. Peroperative, the animal is kept on a heating pad and an injection of fynadine is administered to obtain adequate analgesia during recovery.
12. If an injectable anesthetic is used the animal should be left on a heating pad for 2 to 3 hours to recover. 7. A few small bubbles invariably remain. This should not cause problems.
Delivery of rAAV to the retina -intravitreal injections
8. Experienced virus purifiers may prefer to hold the Beckman tube in one hand and insert the needles with the other rather than using a stand and clamp.
9. DPBS can be used instead of DPBS-sucrose for the first 3 washes.
10. In general AAV particles are robust to freeze-thawing and we prefer not to make more than 2-3 aliquots. It is advisable not to make small aliquots as this can reduce titre.
11. The final pH is important for the subsequent qPCR and should be ideally around 8. We recommend preparing additional tubes with only D-PBS and 1 M NaOH and then checking the exact volume of neutralization solution required to return the pH to 7-8.5.
Check with pH paper or indicator solution. Use the same pipette as you will for the samples.
12. Optimization of the stereotactic coordinates to be used for a particular brain structure includes the injection of a dye, e.g. fast green or methylene blue, and serial sectioning of the brain through the injection area 15 .
13. Some researchers remove a small volume of vitreous just prior to the intravitreal AAV injection. 
